Brief: Dawnrays Pharmaceutical (Holdings) Recommends Final Dividend Of HK$0.05 Per Share
26/03/2021 15:11
March 26 (Reuters) - Dawnrays Pharmaceutical (Holdings) Ltd
2348.HK :
* RECOMMENDS FINAL DIVIDEND OF HK$0.05 PER SHARE
* DAWNRAYS PHARMACEUTICAL FY REVENUE RMB1.02 BILLION, UP
7.8%
* FY PROFIT ATTRIBUTABLE RMB268.1 MILLION VERSUS RMB255.4
MILLION
* RECOMMENDS SPECIAL DIVIDEND OF HK$0.05 PER SHARE
Source text for Eikon: urn:newsml:reuters.com:*:nHKS6SS1gl
Further company coverage: 2348.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Dawnrays Pharmaceutical (Holdings)
See all newsBrief: Dawnrays Pharmaceutical Says Suzhou Dawnrays Commits To Invest Up To RMB100 Mln In Partnership
Brief: Dawnrays Pharmaceutical (Holdings) Final Dividend Of Hk$0.048 Per Share
Brief: Dawnrays Pharmaceutical Reports HY Net Income Attributable Of RMB104.6 MLN
Brief: Dawnrays Pharmaceutical (Holdings) Posts FY Profit Attributable Of Rmb564.9 Million
Brief: Dawnrays Pharmaceutical (Holdings) Appoints Yu Liwei To Act As CEO